Venmax Drugs and Pharmaceuticals Limited (BOM:531015)
India · Delayed Price · Currency is INR 25.30
+0.49 (1.98%)
At close: Jul 16, 2025
BOM:531015 Revenue
In the fiscal year ending March 31, 2025, Venmax Drugs and Pharmaceuticals had annual revenue of 8.07M INR. Venmax Drugs and Pharmaceuticals had revenue of 3.33M in the quarter ending March 31, 2025.
Revenue
8.07M
Revenue Growth
n/a
P/S Ratio
16.74
Revenue / Employee
733.91K
Employees
11
Market Cap
135.16M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 9,646.93B |
| HDFC Bank | 2,728.47B |
| Tata Consultancy Services | 2,561.48B |
| Bharti Airtel | 1,729.85B |
| ICICI Bank | 2,006.54B |
| State Bank of India | 3,429.39B |
| Infosys | 1,647.16B |
| Hindustan Unilever | 631.21B |